Incidence and associated factors with atrial fibrillation in patients with transthyretin amyloidosis cardiomyopathy: Insights from the multicenter REACT-SP registry

Incidence and associated factors with atrial fibrillation in patients with transthyretin amyloidosis cardiomyopathy: Insights from the multicenter REACT-SP registry

Introduction: Atrial fibrillation (AF) presents a treatment challenge in patients with amyloidosis cardiomyopathy, particularly in transthyretin amyloidosis cardiomyopathy (ATTR-CM). Identifying factors associated with AF is important for early diagnosis and intervention. Purpose: This study aims to...

Full description

Saved in:
Bibliographic Details
Main Authors: Cristhian Espinoza Romero, Edileide B. Correia, Alzira De Siqueira Carvalho, Ariane Vieira Scarlatelli, Otavio Rizzi Coelho Filho, Phillip Scheinberg, Murillo De Antunes, Pedro Vellosa Schwartzmann, Sandrigo Mangini, Wilson Marques Junior, Marcus Simões, Renato D. Lopes, Fabio Fernandes
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:International Journal of Cardiology: Heart & Vasculature
Subjects:
Amyloidosis
Thromboembolism
Transthyretin
Atrial fibrillation
Online Access:http://www.sciencedirect.com/science/article/pii/S2352906725000612
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction: Atrial fibrillation (AF) presents a treatment challenge in patients with amyloidosis cardiomyopathy, particularly in transthyretin amyloidosis cardiomyopathy (ATTR-CM). Identifying factors associated with AF is important for early diagnosis and intervention. Purpose: This study aims to identify factors linked to AF in ATTR-CM patients. Methods: The REACT registry, a retrospective, multicenter cohort study, enrolled patients with TTR mutation or wild type. ATTR-CM diagnosis was based on echocardiography and pyrophosphate scintigraphy, with some cases confirmed by biopsy. Binary logistic regression and multivariate analysis were used, with ROC curve analysis determining optimal cutoff points for continuous variables. Results: The study included 273 patients, mostly male (73.2 %), with a median age of 73 years. The ATTR variant was found in 67.3 % (165 patients), and Val142Ile was the most common variant (29.3 %). AF was present in 25.2 % (59 patients). Logistic regression revealed age (per 10-year increase) and left atrial diameter (per 5-mm increase) as predictors of AF, with odds ratios of 1.714 (p = 0.009) and 1.631 (p = 0.002), respectively. ROC curve analysis identified age ≥ 70 years and left atrium > 45 mm as optimal cutoff points (AUC 0.643 and 0.727). Conclusions: In the ATTR amyloidosis registry, older age and increased left atrium size are associated with AF. These findings may help in the early diagnosis and management of AF in ATTR-CM patients.
ISSN:2352-9067

Similar Items